MyFinsight
Home
Blog
About
Contact
Repayment from related
parties
-$759,123
Net cash provided by
investing activities
$47,123
Effect of exchange rate
changes on cash and cash...
$2,640
Canceled cashflow
$712,000
Net decrease in cash
and cash...
-$1,186,661
Canceled cashflow
$49,763
Stock-based compensation
$787,374
Prepaid expenses and
other current assets
-$96,599
Amortization of right-of-use
asset
$86,373
Loss on investment in
equity securities
-$31,416
Tenant security
deposit
$9,077
Depreciation
$5,783
Short-term investments
-$1,168
Common stock
subscription
$319,492
Proceeds from exercise of
warrants
$102,000
Prepayment for long-term
investment
$680,000
Payment for convertible
notes receivable
$32,000
Net cash used in
operating activities
-$894,243
Net cash (used in)
provided by financing...
-$342,181
Canceled cashflow
$1,017,790
Canceled cashflow
$421,492
Net loss
-$1,689,937
Repayment of short-term
loans
$661,650
Due from related
parties
$133,778
Operating lease
liabilities
-$75,109
Accrued expenses and
other current...
-$7,265
Tax payable
-$5,944
Due to related
parties, net
-$57,554
something is missing
-$44,469
Back
Back
Cash Flow
ABVC BIOPHARMA, INC. (ABVC)
ABVC BIOPHARMA, INC. (ABVC)
source: myfinsight.com